Expired contract

NHS National Pharmaceuticals Transition 2019_1 - Contracts Finder Award Notice

Details

Buyer: NHS England
Supplier(s): Multiple suppliers as listed in attached schedule
Value: GBP 28,656,720
Duration: 2 years
Topic: Pharmaceutical products
Published: 26 September 2019
Source: ContractsFinder

Tender description

NHS National Pharmaceuticals Transition 2019_1 Offer reference number: CM/PHG/17/5547 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 34 months Potential periods of call-offs under the framework agreement: LSNE: 01/10/2019 to 30/04/2020 (7 months) CESW: 01/10/2019 to 30/09/2020 (12 months) NWLN: 01/10/2019 to 28/02/2021 (17 months) Awarded product list bortezomib, arsenic, darunavir, atazanavir, ritonavir, miglustat, gefitinib, carglumic acid, clofaribine, ganciclovir, aprepitant, dexmedetomidine, solifenacin, atomoxetine, atovaquone, metaraminol and olopatadine

Timeline

Completed: Award date2 August 2019
Completed: Award published26 September 2019
Current notice
Completed: Contract expiry date28 February 2021

About the buyer

NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

33600000 · Pharmaceutical products
33690000 · Various medicinal products

Decision makers

Connect with the people behind this procurement.

Job title	Phone number	Work email
Head of Procurement	+44 •••• ••••••	••••••••@nhs-england.gov
Commercial Director	+44 •••• ••••••	••••••••@nhs-england.gov
Procurement Manager	+44 •••• ••••••	••••••••@nhs-england.gov
Category Lead	+44 •••• ••••••	••••••••@nhs-england.gov
Senior Buyer	+44 •••• ••••••	••••••••@nhs-england.gov
Contracts Manager	+44 •••• ••••••	••••••••@nhs-england.gov